Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty

Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty

Aim:Gonadotropin-releasing hormone analogs (GnRHa) are standard medical treatments for precocious puberty. Studies on their side effects in adults have shown that these drugs can cause changes in electrocardiography (ECG), along with some cardiovascular effects; however, the number of studies on chi...

Full description

Bibliographic Details
Main Authors:	Eren Er, Aysun Ata, Ali Orgun
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2023-09-01
Series:	Journal of Pediatric Research
Subjects:	ecg gnrh agonist precocious puberty qt qtc qt dispersion qtc dispersion
Online Access:	http://jpedres.org/archives/archive-detail/article-preview/evaluation-of-electrocardiographic-changes-in-girl/62081

Similar Items

Electrocardiographic Findings in Children Treated with Leuprolide Acetate for Precocious Puberty: Does it Cause Prolonged QT?
by: Esma Ebru Altun, et al.
Published: (2024-12-01)

Evaluation of cardiac arrhythmia incidence in patients treated with oral moxifloxacin
by: Casit Olgun Celik, et al.
Published: (2019-01-01)

Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study
by: Hyun Ji Jang, et al.
Published: (2023-11-01)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
by: Doğuş Vurallı, et al.
Published: (2020-03-01)

Smart devices to measure and monitor QT intervals
by: Leendert J. Hoek, et al.
Published: (2023-11-01)

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023-03-01)

Automated Quantification of QT-Intervals by an Algorithm: A Validation Study in Patients with Chronic Obstructive Pulmonary Disease
by: Kohlbrenner D, et al.
Published: (2024-03-01)

Accurate QT correction method from transfer entropy
by: Esa Räsänen, PhD, et al.
Published: (2023-02-01)

Clinical and Laboratory Correlates of QTc Duration in Adult and Pediatric Sickle Cell Disease
by: Xue Yu, et al.
Published: (2023-12-01)

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty
by: Chin-Hui Tseng, et al.
Published: (2023-11-01)

Pilot Study on QTc Interval in Dogs Treated with Domperidone
by: Giulia Donato, et al.
Published: (2024-01-01)

Adult height in girls with idiopathic central precocious puberty treated with triptorelin
by: Raquel Corripio, et al.
Published: (2024-12-01)

Evaluation of clinical and laboratory findings in the differential diagnosis of central precocious puberty and premature thelarche
by: Aslı Beştaş, et al.
Published: (2023-01-01)

Multi-omic analysis of precocious puberty girls: pathway changes and metabolite validation
by: Fang Zhou, et al.
Published: (2024-02-01)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01)

A Short-Duration Gonadotropin-Releasing Hormone Stimulation Test for the Diagnosis of Central Precocious Puberty
by: Maria Chiara Pellegrin, et al.
Published: (2023-12-01)

Early and precocious puberty during the COVID-19 pandemic
by: Sara Prosperi, et al.
Published: (2023-01-01)

Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment
by: Özge Yüce, et al.
Published: (2020-03-01)

Efficacy of leuprolide acetate versus triptorelin pamoate administered every 3 months for treatment of central precocious puberty
by: Thanaporn Thaneetrakool, et al.
Published: (2025-01-01)

A Testicular Leydig Cell Tumor; An Uncommon Cause of Precocious Puberty: A Case Report With Secondary Central Precocious Puberty
by: Seyede Tahereh Mousavi, et al.
Published: (2023-04-01)

Is Cardiac Repolarization Time Different Between Epilepsy Patients On Antiepileptic Drugs and Healthy Subjects?
by: Kezban ASLAN, et al.
Published: (2018-04-01)

Prevalence of QT prolongation and its risk factors in patients with type 2 diabetes
by: Khaled Aburisheh, et al.
Published: (2023-03-01)

Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study
by: Homina Saffar, et al.
Published: (2024-12-01)

Detection of QT interval prolongation using Apple Watch electrocardiogram in children and adolescents with congenital long QT syndrome
by: Jennifer Yee-ming Li, et al.
Published: (2023-08-01)

Use of portable single‐lead electrocardiogram device as an alternative for QTc monitoring in critically ill patients
by: Martin Rebolledo‐Del Toro, et al.
Published: (2024-05-01)

Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty
by: Jungmin Ahn, et al.
Published: (2023-11-01)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
by: Elizabeth J. Rowe, et al.
Published: (2022-12-01)

Central precocious puberty – etiology with particular consideration of neurological causes
by: Izabela Gracjasz-Palikij, et al.
Published: (2020-07-01)

Clinical Management and Therapy of Precocious Puberty in the Sapienza University Pediatrics Hospital of Rome, Italy
by: Ginevra Micangeli, et al.
Published: (2023-10-01)

Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose
by: Borje Darpo, et al.
Published: (2023-02-01)

Evaluation of the diagnostic value of different serum biomarkers in girls with central precocious puberty
by: Yasmine Abdelmeguid, et al.
Published: (2024-07-01)

Relation of homeostasis model of insulin resistance and body mass index with cardiac repolarization inhomogeneity in overweight and obese patients
by: Fatih Kuzu
Published: (2019-03-01)

Influence of GnRH analog therapy on body mass in central precocious puberty
by: Anna Noczyńska, et al.
Published: (2009-03-01)

24 h Holter ECG Monitoring of Patients with Rheumatoid Arthritis—A Potential Role for a Precise Evaluation of QT Interval Duration and Associated Arrhythmic Complications
by: Elena E. Saramet, et al.
Published: (2022-03-01)

Does Basal Morning Luteinizing Hormone (bLH) Predict Central Precocious Puberty (CPP) in Girls?
by: Federico Baronio, et al.
Published: (2024-03-01)

Auxological and Metabolic Parameters of Children Undergoing the Gonadotropin-Releasing Hormone Stimulation Test: Correlations with the Final Diagnosis of Central Precocious Puberty in a Single-Center Study
by: Clelia Cipolla, et al.
Published: (2023-06-01)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
by: Teodoro Durá-Travé, et al.
Published: (2021-03-01)

Erratum: Genotype-specific ECG-based risk stratification approaches in patients with long-QT syndrome
by: Frontiers Production Office
Published: (2023-03-01)

Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome
by: Marina Rieder, et al.
Published: (2022-07-01)

The role of myocardial mechanical and QTc dispersion in detecting significant coronary artery disease
by: Mohamed R Badran
Published: (2022-01-01)